Select Equity Group
LLY icon

Select Equity Group’s Eli Lilly LLY Stock Holding History

Select Equity Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,300
Closed -$3.04M – 180
2026
Q1 		$3.04M Hold
3,300
– – 0.02% 155
2025
Q4 		$3.55M Sell
3,300
-400
-11% -$382K 0.02% 172
2025
Q3 		$2.82M Sell
3,700
-13,700
-79% -$10.2M 0.01% 158
2025
Q2 		$13.6M Buy
17,400
+9,300
+115% +$7.23M 0.06% 105
2025
Q1 		$6.69M Buy
8,100
+100
+1% +$83.2K 0.03% 126
2024
Q4 		$6.18M Hold
8,000
– – 0.02% 105
2024
Q3 		$7.09M Buy
8,000
+200
+3% +$180K 0.03% 101
2024
Q2 		$7.06M Sell
7,800
-1,700
-18% -$1.36M 0.03% 114
2024
Q1 		$7.39M Buy
+9,500
New +$6.76M 0.03% 111

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Select Equity Group's LLY Position: Q2 2026 in Review

Select Equity Group sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 14 shares — an estimated $12.9K sold.

Select Equity Group first reported a position in LLY in Q1 2026 and held it in 1 quarter. The position peaked at $12.9K in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Select Equity Group reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Select Equity Group sold 14 Eli Lilly shares in Q2 2026, an estimated $12.9K.
  • Select Equity Group first reported a position in Eli Lilly in Q1 2026 and held it in 1 quarter.
  • Select Equity Group's Eli Lilly position peaked at $12.9K in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Select Equity Group's 13F filing for Q2 2026, filed 14 Aug 2026.